The Impact of Local Treatment of the Prostate in Patients with Newly Diagnosed Metastatic Prostate Cancer
Dr. Piet Ost presented “The Impact of Local Treatment of the Prostate in Patients with Newly...
Read MoreSelect Page
Piet Ost, MD, PhD, is an Assistant Professor of Radiation Oncology and Adjunct Head of the Radiation Oncology Clinic at Ghent University, in East Flanders, Belgium. He is also Senior Clinical Investigator of the Research Foundation of Flanders. Dr. Ost is a member of the Immuno-Oncology Network of Ghent and has served as Vice-Chairman of the Young Academic Urologist Prostate Cancer Working Group of the European Association of Urology. He is a CRIG (Cancer Research Institute Ghent) group leader whose team focuses on urothelial cancers, particularly prostate cancer. Recently, Dr. Ost’s CRIG group has been investigating prognostic circulating biomarker panels and immunotherapies.
Disclosures:Posted by Piet Ost, MD, PhD | Mar 2017
Dr. Piet Ost presented “The Impact of Local Treatment of the Prostate in Patients with Newly...
Read More